Subcellular Remodeling and Heart Dysfunction in Cardiac Hypertrophy due to Pressure Overload a

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  1999-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1749-6632.1999.tb09228.xPMID 10415524
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The adaptive changes in the isoenzyme pattern of myosin from hypertrophied rat myocardium as a result of pressure overload and physical training

  2005cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Modification of ischemia-reperfusion-induced changes in cardiac sarcoplasmic reticulum by preconditioning.

  1998cited by this paper
• Modulation of contractility in human cardiac hypertrophy by myosin essential light chain isoforms.

  1998cited by this paper
• Modification of sarcoplasmic reticulum gene expression in pressure overload cardiac hypertrophy by etomoxir

  1996cited by this paper
• Differential influences of carnitine palmitoyltransferase-1 inhibition and hyperthyroidism on cardiac growth and sarcoplasmic reticulum phosphorylation.

  1995cited by this paper
• CPT-1 inhibition by etomoxir has a chamber-related action on cardiac sarcoplasmic reticulum and isomyosins.

  1994cited by this paper
• Influence of diet and carnitine palmitoyltransferase I inhibition on myosin and sarcoplasmic reticulum.

  1992cited by this paper
• Modification of subcellular organelles in pressure‐overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor

  1992cited by this paper
• Nitrendipine binding in congestive heart failure due to myocardial infarction.

  1990cited by this paper
• Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats.

  1990cited by this paper
• Altered sympathetic system and adrenoceptors during the development of cardiac hypertrophy.

  1989cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Pathophysiological aspects of myocardial hypertrophy.

  1987cited by this paper
• Mechanisms of the defect in cardiac myofibrillar function during diabetes.

  1985cited by this paper
• Sarcoplasmic reticular and mitochondrial calcium transport in cardiac hypertrophy.

  1985cited by this paper
• Cerebral glucose use measured with [14C]glucose labeled in the 1, 2, or 6 position.

  1985cited by this paper
• Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy.

  1983cited by this paper
• Heat, mechanics, and myosin ATPase in normal and hypertrophied heart muscle.

  1982cited by this paper
• Physiologic cardiac hypertrophy corrects contractile protein abnormalities associated with pathologic hypertrophy in rats.

  1982cited by this paper
• Heat, mechanics, and myosin ATPase in normal and hypertrophied heart muscle.

  1982cited by this paper
• Myosin Isoenzymic Changes in Several Models of Rat Cardiac Hypertrophy

  1981cited by this paper
• Myocyte Growth without Physiological Impairment in Gradually Induced Rat Cardiac Hypertrophy

  1981cited by this paper
• Enhanced calcium transport by sarcoplasmic reticulum in mild cardiac hypertrophy.

  1980cited by this paper
• The Cardiac Hypertrophy Process

  1979cited by this paper
• Defective calcium pump in the sarcoplasmic reticulum of the hypertrophied rabbit heart.

  1979cited by this paper
• The ATPase activity of subfragment-1 from the hypertrophied heart.

  1978cited by this paper
• Canine cardiac myosin with special reference to pressure overload cardiac hypertrophy. II. Myosin ATPase.

  1978cited by this paper
• The Mechanical Characteristics of Hypertrophied Rabbit Cardiac Muscle in the Absence of Congestive Heart Failure: The Contractile and Series Elastic Elements

  1977cited by this paper
• Intracellular calcium and myocardial contractility. V. Calcium uptake of sarcoplasmic reticulum fractions in hypertrophied and failing rabbit hearts.

  1974cited by this paper
• Mitochondria and sarcoplasmic reticulum function in cardiac hypertrophy and failure.

  1973cited by this paper

• Involvement of phospholipase C in the norepinephrine-induced hypertrophic response in Cardiomyocytes

  2022cites this paper
• Oxidative Stress as A Mechanism for Functional Alterations in Cardiac Hypertrophy and Heart Failure

  2021cites this paper
• Relation of angiography to hematological, hormonal and some biochemical variables in coronary artery bypass graft patients

  2019cites this paper
• Relation of angiography to hematological, hormonal and some biochemical variables in coronary artery bypass graft patients

  2019cites this paper
• Mechanisms for the transition from physiological to pathological cardiac hypertrophy.

  2019cites this paper
• Rosuvastatin improves myocardial hypertrophy after hemodynamic pressure overload via regulating the crosstalk of Nrf2/ARE and TGF‐&bgr;/ smads pathways in rat heart

  2018cites this paper
• Protective effect of hydrogen-rich saline on pressure overload-induced cardiac hypertrophyin rats: possible role of JAK-STAT signaling

  2018cites this paper
• Emerging drugs for the treatment of angina pectoris

  2016cites this paper
• Calcium handling proteins: structure, function, and modulation by exercise

  2014cites this paper
• The Effects of 17-Methoxyl-7-Hydroxy-Benzene-Furanchalcone on the Pressure Overload-Induced Progression of Cardiac Hypertrophy to Cardiac Failure

  2014cites this paper
• Differences in Concentric Cardiac Hypertrophy and Eccentric Hypertrophy

  2013cites this paper
• Increased end diastolic wall stress precedes left ventricular hypertrophy in dilative heart failure--use of the volume-based wall stress index.

  2012cites this paper
• Role of various proteases in cardiac remodeling and progression of heart failure

  2012cites this paper
• K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.

  2009cites this paper
• Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.

  2008cites this paper
• Emerging drugs for acute and chronic heart failure: current and future developments

  2007cites this paper
• Dependence of changes in beta-adrenoceptor signal transduction on type and stage of cardiac hypertrophy.

  2007cites this paper
• Relation of B-type natriuretic peptide to left ventricular wall stress as assessed by cardiac magnetic resonance imaging in patients with dilated cardiomyopathy.

  2007cites this paper
• Mechanistic basis of differences in Ca2+ -handling properties of sarcoplasmic reticulum in right and left ventricles of normal rat myocardium.

  2006cites this paper
• Regulation of the sarcoplasmic reticulum Ca2+-ATPase expression in the hypertrophic and failing heart.

  2006cites this paper
• Carnitine Palmitoyltransferase-I, a New Target for the Treatment of Heart Failure

  2004cites this paper
• Justification for antioxidant preconditioning (or how to protect insulin-mediated actions under oxidative stress)

  2003cites this paper
• Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction.

  2001cites this paper
• Attenuation of changes in sarcoplasmic reticular gene expression in cardiac hypertrophy by propranolol and verapamil

  2000influential citation
• Altered expression of proteins of metabolic regulation during remodeling of the left ventricle after myocardial infarction.

  2000cites this paper